Published in Hepatitis Weekly, September 24th, 2007
"In fact, for some measurements and some kava doses, the injury marker readings were below control...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.